HBIOHARVARD BIOSCIENCE INC

Nasdaq harvardbioscience.com


$ 2.86 $ -0.05 (-1.72 %)    

Friday, 28-Jun-2024 15:59:49 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 2.85
$ 2.93
$ 0.00 x 0
$ 0.00 x 0
$ 2.84 - $ 2.95
$ 2.75 - $ 5.88
1,169,875
na
123.7M
$ 1.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 04-26-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-11-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 03-17-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 04-29-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 harvard-bioscience-continues-to-expect-2024-gross-margin-of-approximately-60-and-adjusted-ebitda-margin-in-the-mid-teens

For the full year 2024 revenues to be approximately flat versus 2023. Company sees second half growth versus both first half of...

 harvard-bioscience-q1-adj-002-inline-sales-2451m-miss-2579m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This ...

 harvard-bioscience-q4-adj-eps-004-misses-005-estimate-sales-2815m-miss-2911m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of Adj $0.04 per share which missed the analyst consensus estimate...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 harvard-bioscience-to-showcase-latest-solutions-for-preclinical-and-organoid-applications-at-society-of-toxicology-meeting

Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that it will be showcasing its latest product innovations at the Society...

 harvard-bioscience-q3-adjusted-eps-001-misses-004-estimate-sales-2536m-miss-2802m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of ...

 earnings-scheduled-for-november-7-2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

 harvard-bioscience-and-etisense-announce-agreement-for-supply-and-distribution-of-decro-miniature-telemetry-jacket-platform-for-pre-clinical-research

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands...

 harvard-bioscience-expects-fy23-revenues-of-116m-120m-consensus-12076m

This expected growth anticipates an approximate 4 percentage point headwind from discontinued products.

 harvard-bioscience-q2-adj-eps-004-misses-005-estimate-sales-2880m-miss-2950m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly adj earnings of $0.04 per share which missed the analyst consensus estimate...

 earnings-scheduled-for-august-8-2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share o...

 benchmark-reiterates-speculative-buy-on-harvard-bioscience-maintains-7-price-target

Benchmark analyst Bruce Jackson reiterates Harvard Bioscience (NASDAQ:HBIO) with a Speculative Buy and maintains $7 price ta...